“‘IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.’”, Mediterr J Hematol Infect Dis, vol. 8, p. e2016047, Oct. 2016, doi: 10.4084/mjhid.2016.047.